As part of the program, INSA-Lyon will receive, at no cost, renewable one-year licenses of Pharsight(R) Trial Simulator(TM), Pharsight's computer-assisted trial design tool (CATD), which is currently in use by leading drug developers to optimize the design and conduct of clinical studies.
Initially, the companies will market an integration of Pharsight's Computer-Assisted Trial Design methodology, the Pharsight Trial Simulator and iBiomatics' web- based platform for biomedical informatics.
Nasdaq:MLNM) and Pharsight Corporation (Nasdaq:PHST) today announced that the two companies have entered into an agreement to evaluate and apply Pharsight's computer-assisted trial design and decision making methodologies, to Millennium's drug development programs.
In the initial stage of the collaboration, Pharsight and iBiomatics will market a solution that integrates Pharsight's Computer-Assisted Trial Design (CATD) methodology and the Pharsight Trial Simulator(TM), with iBiomatics' Web-based platform for biomedical informatics.
4 /PRNewswire/ -- Pharsight Corporation, the leader in computer-assisted trial design (CATD) software and services announced the release of Pharsight(R) Trial Designer 1.
Pharsight's computer-assisted trial design solution, the Pharsight(R) Trial Designer, was designed under an alliance with the ECPM, resulting in the incorporation of ECPM's simulation technology into the Pharsight product.
Pharsight Corporation, located in the midst of Silicon Valley and Biotech Bay, provides drug companies with computer-assisted trial design (CATD) software to design better, and eventually fewer, clinical trials.
BUSINESS WIRE)--July 21, 1998--Pharsight Corporation, the leader in computer-assisted trial design (CATD) software and services, today announced that the Clinical Pharmacology/ Pharmacokinetic division of Eli Lilly and Company (NYSE:LLY) has purchased Pharsight's modeling and analysis software to aid research and development.
